Related references
Note: Only part of the references are listed.Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study
M. D. Bellin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study
P. A. Senior et al.
DIABETIC MEDICINE (2017)
Improvement of islet graft function using liraglutide is correlated with its anti-inflammatory properties
A. Langlois et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation
Allan Langlois et al.
PLOS ONE (2016)
Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice
Yan-ju Wu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
Jyuhn-Huarng Juang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Exendin-4 Protects Hypoxic Islets From Oxidative Stress and Improves Islet Transplantation Outcome
M. Padmasekar et al.
ENDOCRINOLOGY (2013)
Dipeptidyl Peptidase IV Inhibition Activates CREB and Improves Islet Vascularization through VEGF-A/VEGFR-2 Signaling Pathway
Balaji Samikannu et al.
PLOS ONE (2013)
A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats
Atul Sureshrao Akarte et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes
S. M. Poucher et al.
DIABETES OBESITY & METABOLISM (2012)
Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice
Y. Takeda et al.
DIABETOLOGIA (2012)
Total Pancreatectomy and Islet Autotransplantation for Chronic Pancreatitis
David E. R. Sutherland et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes
Mi-Kyung Kim et al.
LIFE SCIENCES (2012)
Both sitagliptin analogue & pioglitazone preserve the β-cell proportion in the islets with different mechanism in non-obese and obese diabetic mice
Jin-A Yeom et al.
BMB REPORTS (2011)
A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis
Jae Min Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Improved Outcome of Islet Transplantation in Partially Pancreatectomized Diabetic Mice by Inhibition of Dipeptidyl Peptidase-4 With Sitagliptin
Young-Seok Kim et al.
PANCREAS (2011)
Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts
Lei Tian et al.
TRANSPLANT INTERNATIONAL (2011)
Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats
Heung Yong Tin et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation
Su-Jin Kim et al.
DIABETES (2009)
Differential Importance of Glucose-Dependent Insulinotropic Polypeptide vs Glucagon-Like Peptide 1 Receptor Signaling for Beta Cell Survival in Mice
Adriano Maida et al.
GASTROENTEROLOGY (2009)
GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis
Kentaro Toyoda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets
Jyuhn-Huarng Juang et al.
CELL TRANSPLANTATION (2008)
Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice
Su-Jin Kim et al.
DIABETES (2008)
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice
S. Merani et al.
ENDOCRINOLOGY (2008)
Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyano-pyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-L-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes
Qianni Cheng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat-fed mice
Benjamin J. Lamont et al.
DIABETES (2008)
The role of gut hormones in glucose homeostasis
Daniel J. Drucker
JOURNAL OF CLINICAL INVESTIGATION (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
International trial of the edmonton protocol for islet transplantation
A. M. James Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes
James Mu et al.
DIABETES (2006)
Biological and biomaterial approaches for improved islet transplantation
Ajit S. Narang et al.
PHARMACOLOGICAL REVIEWS (2006)
Five-year follow-up after clinical islet transplantation
EA Ryan et al.
DIABETES (2005)
Glucagon-like peptide 1 agonists and the development and growth of pancreatic β-cells
JF List et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
GLP-1 inhibition of pancreatic islet cell apoptosis
IA Urusova et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Dipeptidyl peptidase IV inhibitor treatment stimulates β-cell survival and islet neogenesis in streptozotocin-induced diabetic rats
JA Pospisilik et al.
DIABETES (2003)
Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis
DJ Drucker
MOLECULAR ENDOCRINOLOGY (2003)
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell glucose responsiveness in VDF (fa/fa) Zucker rats
JA Pospisilik et al.
DIABETES (2002)
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
AMJ Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
